Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the presentation of data from its first-in-human, dose-ranging Phase 1 LUMINA trial of AMX0114 at the European ...
Epic cinematic racing meets Balatro – this really could be the racer of the year ...
As more buyers choose to wait on the sidelines due to rate rises and tax reforms, those in the smaller capitals can look to ...
Good day, and welcome to the FedEx Fourth Quarter and Fiscal 2026 Earnings Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to ...
NEW YORK, NY / / June 23, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results